Deep Medicine Acquisition Stock Working Capital
| DMAQDelisted Stock | USD 11.59 0.12 1.02% |
Deep Medicine Acquisition fundamentals help investors to digest information that contributes to Deep Medicine's financial success or failures. It also enables traders to predict the movement of Deep Stock. The fundamental analysis module provides a way to measure Deep Medicine's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Deep Medicine stock.
Deep |
Deep Medicine Acquisition Company Working Capital Analysis
Deep Medicine's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Deep Medicine Working Capital | 6.98 M |
Most of Deep Medicine's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Deep Medicine Acquisition is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
CompetitionAccording to the company's disclosures, Deep Medicine Acquisition has a Working Capital of 6.98 M. This is 99.85% lower than that of the Capital Markets sector and significantly higher than that of the Financials industry. The working capital for all United States stocks is 99.53% higher than that of the company.
Deep Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Deep Medicine's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Deep Medicine could also be used in its relative valuation, which is a method of valuing Deep Medicine by comparing valuation metrics of similar companies.Deep Medicine is currently under evaluation in working capital category among its peers.
Deep Fundamentals
| Return On Asset | -0.0176 | |||
| Current Valuation | 15.74 M | |||
| Shares Outstanding | 4.36 M | |||
| Shares Owned By Insiders | 74.08 % | |||
| Shares Owned By Institutions | 28.73 % | |||
| Number Of Shares Shorted | 10.3 K | |||
| Price To Book | 22.01 X | |||
| EBITDA | (3.99 M) | |||
| Net Income | (400.23 K) | |||
| Cash And Equivalents | 707.98 K | |||
| Cash Per Share | 0.04 X | |||
| Total Debt | 1.86 M | |||
| Current Ratio | 229.55 X | |||
| Book Value Per Share | (1.69) X | |||
| Cash Flow From Operations | (1.04 M) | |||
| Short Ratio | 0.33 X | |||
| Earnings Per Share | (0.13) X | |||
| Beta | 0.017 | |||
| Market Capitalization | 12.9 M | |||
| Total Asset | 9.78 M | |||
| Retained Earnings | (6.44 M) | |||
| Working Capital | 6.98 M | |||
| Z Score | 2.74 | |||
| Net Asset | 9.78 M |
About Deep Medicine Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Deep Medicine Acquisition's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Deep Medicine using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Deep Medicine Acquisition based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Deep Medicine
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Deep Medicine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Deep Medicine will appreciate offsetting losses from the drop in the long position's value.Moving against Deep Stock
| 0.86 | PKX | POSCO Holdings | PairCorr |
| 0.84 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
| 0.83 | KO | Coca Cola Fiscal Year End 11th of February 2025 | PairCorr |
| 0.67 | EC | Ecopetrol SA ADR | PairCorr |
| 0.57 | PTAIY | Astra International Tbk | PairCorr |
The ability to find closely correlated positions to Deep Medicine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Deep Medicine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Deep Medicine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Deep Medicine Acquisition to buy it.
The correlation of Deep Medicine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Deep Medicine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Deep Medicine Acquisition moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Deep Medicine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in Deep Stock
If you are still planning to invest in Deep Medicine Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Deep Medicine's history and understand the potential risks before investing.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stocks Directory Find actively traded stocks across global markets |